BRIGHTSTAR LOTTERY PLC financials

SEC pipeline catching up: most recent reported quarter (2026-03-31) isn't incorporated yet — this page is anchored to 2025-12-31 (FY 2025 · 20-F). New filings land within a few weekday pipeline runs.
BRSL CIK 0001619762

Source: EDGAR filings · Built 2026-06-02T02:30:58Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -423.00M 895.00M 857.00M 728.00M 727.00M 601.00M
EBITDA 890.00M 967.00M 1.24B 1.43B 459.00M
Working Capital -736.00M 3.48B 432.00M 283.00M 573.00M 825.00M
Net Debt 2.85B 4.91B 5.44B 5.47B 6.28B 7.70B
Operating Margin 27.31% 29.74% 28.61% 22.06% -3.44%
Net Margin 5.85% 13.85% 6.17% 10.59% 11.79% -28.83%
Return on Equity (ROE) 16.80% 21.07% 10.81% 19.24% 37.60% -115.57%
Return on Assets (ROA) 1.61% 3.39% 1.49% 2.64% 4.26% -6.91%
Current Ratio 0.76× 2.29× 1.26× 1.15× 1.30× 1.32×
Debt-to-Equity 4.91× 3.32× 4.12× 4.24× 5.36× 11.07×
Effective Tax Rate 55.18% 47.98% 45.70% 27.46% 51.80% -3.30%
Cash Conversion Ratio -0.67× 3.02× 6.49× 3.27× 2.03× -0.96×
Accruals Ratio 0.03× -0.07× -0.08× -0.06× -0.04× -0.14×
SBC % of Revenue 0.60% 1.51% 1.34% 1.31% 0.86% -0.22%
CapEx Coverage -0.31× 6.77× 6.53× 5.26× 3.90× 3.27×
Free Cash Flow Per Share $-2.15 $4.39 $4.22 $3.59 $3.51 $2.94

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 20.92× 10.33× 35.60× 16.80× 12.41×
P/FCF 4.03× 6.49× 6.32× 8.23× 5.77×
FCF Yield 24.84% 15.40% 15.81% 12.15% 17.33%
EV / EBITDA 9.52× 11.31× 8.08× 8.52× 24.33×
P/S 1.15× 1.42× 2.17× 1.74× 1.44× 1.11×
P/B 3.31× 2.16× 3.81× 3.16× 4.59× 4.47×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 2.51B 2.51B 2.53B 2.60B 4.09B 3.12B
Revenues 2.51B 2.51B 2.53B 2.60B 4.09B 3.12B
Research and Development Expense 47.00M 43.00M 36.00M 45.00M 238.00M 191.00M
Selling, General and Administrative Expense 215.00M 235.00M 246.00M 400.00M 810.00M 707.00M
Operating Expenses 1.83B 1.78B 1.85B 3.19B 3.22B
Operating Income (Loss) 686.00M 752.00M 743.00M 902.00M -107.00M
Income Tax Expense (Benefit) 165.00M 250.00M 223.00M 212.00M 274.00M 28.00M
Net Income (Loss) Attributable to Parent 147.00M 348.00M 156.00M 275.00M 482.00M -898.00M
Earnings Per Share, Basic $0.74 $1.73 $0.78 $1.36 $2.35 $-4.39
Weighted Average Number of Shares Outstanding, Basic 197.00M 202.00M 200.00M 202.00M 205.00M 204.72M
Earnings Per Share, Diluted $0.74 $1.71 $0.77 $1.35 $2.33 $-4.39
Weighted Average Number of Shares Outstanding, Diluted 197.00M 204.00M 203.00M 203.00M 207.00M 204.72M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 1.45B 584.00M 508.00M 590.00M 591.00M 907.00M
Assets, Current 2.34B 6.17B 2.12B 2.13B 2.49B 3.44B
Assets 9.16B 10.28B 10.46B 10.43B 11.32B 12.99B
Liabilities, Current 3.07B 2.69B 1.69B 1.85B 1.91B 2.62B
Long-term Debt, Excluding Current Maturities 4.06B 5.15B 5.66B 5.69B 6.48B 7.86B
Liabilities 7.57B 8.22B 8.51B 8.45B 9.35B 11.43B
Stockholders' Equity Attributable to Parent 875.00M 1.65B 1.44B 1.43B 1.28B 777.00M
Common Stock, Shares, Outstanding 186.85M 201.86M 200.48M 199.08M 203.69M 204.86M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -99.00M 1.05B 1.01B 899.00M 978.00M 866.00M
Net Cash Provided by (Used in) Investing Activities 3.50B -357.00M -393.00M 168.00M 636.00M -269.00M
Payments for Repurchase of Common Stock 271.00M 0 0 115.00M 41.00M 0
Net Cash Provided by (Used in) Financing Activities -2.72B -606.00M -610.00M -1.06B -1.90B -438.00M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (BRSL CIK 0001619762), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

THC

TENET HEALTHCARE CORP

COCH

ENVOY MEDICAL, INC.

LWAY

LIFEWAY FOODS, INC.